Telehealth is not a new phenomenon, but the pandemic has made telemedicine a necessity. It has forced the healthcare sector to see telehealth as a virtual care ecosystem and not simply as tele/video consultation. As a result, physicians and consumers are using telemedicine in forms such as televisits and consultation, remote monitoring, medication management, access to specialised care that is otherwise limited, tele-ICU and post-acute-care integration.
Healthcare consumers and providers are adopting telemedicine technology to meet growing demand for risk-free, convenient and cost-effective access to care. Strong continued uptake, favourable consumer perception, a supportive regulatory environment and strong investment in this space are contributing to its adoption. However, to realise the full potential of virtually enabled care ecosystems, payers, providers and consumers need to adopt telemedicine as part of their routine engagements.
Domain expertise across the life sciences and healthcare ecosystem, with specialised expertise in digital healthcare
Real-world expertise from solving the challenges of 5 of the top 8 global pharmaceutical giants, meeting their strategic and business research needs
Actionable insights providing direct, meaningful action items for optimised decision making
Dedicated team that understands the specific needs of the life sciences sector, shares customised output and works towards building long-term client relationships
Flexible engagement models supporting changing requirements and dynamic market conditions to scale up or down, based on client requirement
Improved savings through operational cost savings, a dedicated team and automation
100% data confidentiality with industry-benchmarked SOC2 compliance
Cross-divisional support providing on-demand data analytics, financial services, deal tracking, commercial due diligence, M&A analysis and design and editorial support